Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
From Rhythm Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers RYTM
News headline image
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Invivyd
Via GlobeNewswire
Tickers IVVD
News headline image
RYTHM, Inc. Reports Second Quarter 2026 Results
From RYTHM, Inc.
Via GlobeNewswire
Tickers RYM
News headline image
Certara Reports Second Quarter 2026 Financial Results
From Certara
Via GlobeNewswire
Tickers CERT
News headline image
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
From CAMP4 Therapeutics
Via GlobeNewswire
Tickers CAMP
News headline image
BellRing Brands Reports Results for the Third Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook
From BellRing Brands, Inc.
Via GlobeNewswire
Tickers BRBR
News headline image
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
From Beam Therapeutics
Via GlobeNewswire
Tickers BEAM
News headline image
TRISO-X Announces 70-Acre Expansion of Oak Ridge Nuclear Fuel Campus
From X-Energy, Inc.
Via GlobeNewswire
Tickers XE
News headline image
Aeluma Names Jason Taylor Senior Director of Program and Project Management
From Aeluma, Inc.
Via GlobeNewswire
Tickers ALMU
News headline image
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
From TELA Bio, Inc.
Via GlobeNewswire
Tickers BFLY TELA
News headline image
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026
From Shoals Technologies Group
Via GlobeNewswire
Tickers SHLS
News headline image
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
From Lisata Therapeutics, Inc.
Via GlobeNewswire
Tickers LSTA
News headline image
Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference
From Remix Therapeutics
Via GlobeNewswire
News headline image
TOP Financial Group Limited Announces Strategic Expansion to Launch Artificial Intelligence Division and Integrate Advanced AI Across Core Brokerage and FinTech Operations
From TOP Financial Group Limited
Via GlobeNewswire
Tickers TOP
News headline image
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
From Sagimet Biosciences Inc.
Via GlobeNewswire
Tickers SGMT
News headline image
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
Tickers TLSA
News headline image
Strata Critical Medical Announces Second Quarter 2026 Results
From Strata Critical Medical, Inc
Via GlobeNewswire
Tickers SRTA
News headline image
Cipher Digital Provides Second Quarter 2026 Business Update
From Cipher Digital Inc.
Via GlobeNewswire
Tickers CIFR CIFRW
News headline image
LGI Homes, Inc. Reports Strong Second Quarter 2026 Results and Increases Full-Year 2026 Average Sales Price and Homebuilding Gross Margin Guidance Ranges
From LGI Homes, Inc.
Via GlobeNewswire
Tickers LGIH
News headline image
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Odyssey Therapeutics Inc
Via GlobeNewswire
Tickers ODTX
News headline image
Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases
From Dianthus Therapeutics, Inc.
Via GlobeNewswire
Tickers DNTH
News headline image
Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results
From The Descartes Systems Group Inc
Via GlobeNewswire
Tickers DSGX TSX:DSG
News headline image
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Arvinas Inc.
Via GlobeNewswire
Tickers ARVN
News headline image
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy
From Vantage Biosciences
Via GlobeNewswire
News headline image
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
From Rhythm Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers RYTM
News headline image
ScottsMiracle-Gro Announces Financial Targets and Capital Allocation Strategy During Investor Day 2026 at NYSE
From Scotts Miracle-Gro Company (The)
Via GlobeNewswire
Tickers SMG
News headline image
Senmiao Technology Limited Engages Strategic Advisory Firm to Support Government Relations and Strategic Advisory Efforts
From Senmiao Technology Limited
Via GlobeNewswire
Tickers AIHS
News headline image
BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
Descartes Introduces New AI-Powered Free Trade Intelligence (FTI) Solution to Help Reduce Trade Costs
From The Descartes Systems Group Inc
Via GlobeNewswire
Tickers DSGX TSX:DSG
News headline image
Westlake Corporation Reports Second Quarter 2026 Results
From Westlake Corporation
Via GlobeNewswire
Tickers WLK
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.